Skip to main navigation
Cue Logo
Skip to Content
Cue Logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Corporate Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Investor Relations

News
Releases

Date Title
Aug 29, 2022
Cue Health Launches Cue Care™ Nationwide to Provide Same-Day, At-Home, Test-to-Treatment Service for COVID-19
Aug 24, 2022
Cue Health Provides Enhanced Care & Protection for Immunocompromised Populations & Clinical Care Teams at Fresenius Kidney Care
Aug 17, 2022
Independent Study Shows Cue Health's Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
Aug 10, 2022
Cue Health Reports Second Quarter 2022 Results
Aug 03, 2022
Cue Health to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
Jul 27, 2022
Cue Health to Announce Second Quarter 2022 Financial Results
Jul 13, 2022
Cue Health Appoints Allison Blackwell Chief Human Resources Officer
Jun 01, 2022
Cue Health to Present at Upcoming Investor Conferences
May 11, 2022
Cue Health Reports First Quarter 2022 Results
May 02, 2022
Cue Health Makes De Novo Submission to FDA for Full Clearance of Its Molecular COVID-19 Test

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Next page next ›
  • Last page last »
Displaying 11 - 20 of 38

Shareholder Tools

Print Page Print Page
Email Alerts Email Alerts
RSS RSS
Contact Contact

This website contains depictions of contemplated future products and future care offerings that are still under development by Cue Health and that have not received regulatory authorization, clearance or approval. Currently, the only products authorized for commercial sale in the United States are Cue Health’s COVID-19 tests, which are currently commercially available in the United States pursuant to two Emergency Use Authorizations from the U.S. Food & Drug Administration.

  • © 2023 Cue Health Inc. All rights reserved. Cue and the Cue logo are registered trademarks of Cue Health Inc.